Yiqun Li
Cancer Cell · with Boggon · 2007
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Whom Yiqun Li trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Yiqun Li's perspective
Ordered by how strongly the researchers Yiqun Li trusts endorse each paper. Same corpus, a different order for every researcher.
- Improved methods for building protein models in electron density maps and the location of errors in these models.
- Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways (Science)
- Refinement of macromolecular structures by the maximum-likelihood method.
- Untangling the ErbB signalling network (Nature reviews. Molecular cell biology)
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy (Science)
- EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. (Proceedings of the National Academy of Sciences of the United States of America)
- Crystallography & NMR system: A new software suite for macromolecular structure determination.
- Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline Inhibitor* (Journal of Biological Chemistry)
- ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy. (Cancer Research)
- Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain (PLoS Medicine)